| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 异去氧苦地胆苦素; Isodeoxyelephantopin | CFN97745 | 38927-54-7 | C19H20O6 = 344.36 | 10mg | QQ客服：2159513211 |
| 沼菊素氯海德林; Enhydrin chlorohydrin | CFN97746 | 38230-99-8 | C23H29ClO10 = 500.93 | 5mg | QQ客服：215959384 |
| 罗布麻酚A; Apocynol A | CFN97750 | 358721-33-2 | C13H20O3 = 224.30 | 5mg | QQ客服：215959384 |
| 柳杉二醇11-鼠李糖苷; Cryptomeridiol 11-rhamnoside | CFN97756 | 349112-30-7 | C21H38O6 = 386.53 | 5mg | QQ客服：1457312923 |
| 青蒿琥酯； 青蒿脂; Artesunate | CFN90313 | 88495-63-0 | C19H28O8 = 384.42 | 20mg | QQ客服：1413575084 |
| 去氧苦地胆苦素; Deoxyelephantopin | CFN97764 | 29307-03-7 | C19H20O6 = 344.36 | 10mg | QQ客服：2056216494 |
| 2alpha-羟基泽兰内酯; 2-Hydroxyeupatolide | CFN90346 | 72229-33-5 | C15H20O4 = 264.32 | 5mg | QQ客服：1457312923 |
| Chlorouvedalin; Chlorouvedalin | CFN97775 | 24694-80-2 | C23H29ClO9 = 484.93 | 5mg | QQ客服：1457312923 |
| Uvedalin; Uvedalin | CFN97776 | 24694-79-9 | C23H28O9 = 448.47 | 5mg | QQ客服：2159513211 |
| 3,11,12-三羟基螺旋菌-1(10)-烯-2-酮; 3,11,12-Trihydroxyspirovetiv-1(10)-en-2-one | CFN97784 | 220328-04-1 | C15H24O4 = 268.35 | 5mg | QQ客服：3257982914 |
| 地胆草种内酯; Scabertopin | CFN97798 | 185213-52-9 | C20H22O6 = 358.39 | 5mg | QQ客服：1457312923 |
| 林泽兰内酯B; Eupalinilide B | CFN90378 | 757202-08-7 | C20H24O6 = 360.41 | 10mg | QQ客服：215959384 |
| 林泽兰内酯C; Eupalinilide C | CFN90379 | 757202-11-2 | C20H24O7 = 376.4 | 5mg | QQ客服：2056216494 |
| 林泽兰内酯D; Eupalinilide D | CFN90380 | 757202-14-5 | C15H19ClO5 = 314.76 | 10mg | QQ客服：1457312923 |
| 野马追内酯A; Eupalinolide A | CFN90381 | 877822-41-8 | C24H30O9 = 462.49 | 20mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)